You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mazindol

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Narcolepsy Type 1, Narcolepsy With Cataplexy Trial (NLS-2, Placebo)

Not yet recruiting
  • Narcolepsy Type 1
  • Narcolepsy With Cataplexy
  • (no location specified)
Jun 21, 2023

Narcolepsy, Excessive Daytime Sleepiness, Cataplexy Narcolepsy Trial in United States (mazindol extended release, Placebo)

Completed
  • Narcolepsy
  • +2 more
  • mazindol extended release
  • Placebo
  • Birmingham, Alabama
  • +21 more
Aug 11, 2022

Narcolepsy With Cataplexy, Narcolepsy, Narcolepsy Without Cataplexy Trial in United States (Mazindol)

Enrolling by invitation
  • Narcolepsy With Cataplexy
  • +2 more
  • Mazindol
  • Birmingham, Alabama
  • +21 more
Jun 1, 2022

Cocaine-Related Disorders Trial in New Haven (Mazindol)

Completed
  • Cocaine-Related Disorders
  • Mazindol
  • New Haven, Connecticut
    VA Connecticut Healthcare System
Jun 17, 2020

Overweight, Obesity Trial in Rome ("Acqua Santa di Chianciano"® (sulphate-bicarbonate-calcium water), Tap water)

Withdrawn
  • Overweight
  • Obesity
  • "Acqua Santa di Chianciano"® (sulphate-bicarbonate-calcium water)
  • Tap water
  • Rome, Italy
    Department of Translational and Precision Medicine, Sapienza Uni
Apr 29, 2021

Attention Deficit Disorder With Hyperactivity Trial in United States (mazindol)

Completed
  • Attention Deficit Disorder With Hyperactivity
  • mazindol
  • Newport Beach, California
  • +6 more
Apr 4, 2017

Mazindol in ADHD : Open-label, Efficacy, Safety and

Completed
  • Attention Deficit Hyperactivity Disorder
    • Paris, France
      Hopital Robert Debre
    Sep 30, 2009